5-MeO-DMT Powder (Fumarate)
€ 35,00 – € 350,00Price range: € 35,00 through € 350,00
5-MeO-DMT Powder (Fumarate) is described as a research material associated with the fumarate salt of 5-methoxy-N,N-dimethyltryptamine.
The named compound belongs to the substituted tryptamine family and contains a methoxy-substituted indole framework with an N,N-dimethylaminoethyl side chain.
The supplied source identifies the product as a powder in fumarate salt form, intended for controlled analytical and laboratory research.
Its stated scientific context includes compound identification, chemical characterization, analytical method development, and reference-oriented investigation of substituted tryptamines.
However, the exact fumarate stoichiometry, ingredient purity, crystalline characteristics, and batch-specific analytical identity have not been independently established.
The source refers to Certificates of Analysis, batch tracking, and laboratory verification where applicable. No actual supporting documentation accompanied these statements.
The material is not established as a certified reference material or validated quantitative calibration standard.
For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.
5-MeO-DMT (Fumarate) – Substituted Tryptamine Research Material
Product Overview
5-MeO-DMT Fumarate refers to a material described as containing the fumarate salt of 5-methoxy-N,N-dimethyltryptamine.
The named parent compound belongs to the substituted tryptamine family and is classified as a 5-methoxytryptamine derivative.
Its molecular framework contains a methoxy-substituted indole ring and an aminoethyl side chain bearing two methyl substituents on the nitrogen atom.
The supplied source identifies the product as a fumarate salt preparation intended for analytical and reference-oriented laboratory research.
The fumarate designation is chemically relevant because salt composition can influence molecular-weight calculations and physicochemical characteristics.
However, the actual product’s salt stoichiometry and analytical identity have not been independently established.
The source describes the material as a stable crystalline powder and emphasizes consistent material properties.
No actual batch-specific analytical report, independent identity certificate, or product inspection record accompanied the information.
The stated product characteristics therefore remain source-provided specifications.
5-MeO-DMT Powder (Fumarate) is not established here as a certified reference material, validated quantitative calibrator, or approved pharmaceutical preparation.
Chemical Identity & Classification
The supplied source identifies 5-MeO-DMT as 5-methoxy-N,N-dimethyltryptamine, a substituted tryptamine.
The product is specifically described as a fumarate salt preparation of that compound.
The supplied product information includes:
- Common designation: 5-MeO-DMT
- Chemical name: 5-Methoxy-N,N-dimethyltryptamine
- Reported chemical form: Fumarate salt
- Chemical classification: Substituted tryptamine; 5-methoxytryptamine derivative
- Reported presentation: Powder
- Intended designation: Research Use Only
The source does not provide a CAS Registry Number, molecular formula, molecular weight, complete systematic chemical name, or verified fumarate stoichiometry.
These details should not be inferred from the product title alone.
The molecular formula and molecular weight of the neutral parent compound are not interchangeable with those of its fumarate salt.
Fumarate preparations may differ in acid-to-base stoichiometry, and the supplied information does not establish the exact composition of the finished material.
No structural analysis or batch-specific identity report was supplied.
Researchers may consult PubChem for public chemical-reference information, while ensuring that any selected record corresponds to the actual chemical form being examined.
Chemical & Physical Characteristics
The supplied source describes the product as a crystalline fumarate powder.
No actual product-specific inspection report, particle-size measurement, melting-point determination, or quantitative solubility profile was provided.
The stated physical presentation therefore remains a source-provided description.
The named parent compound contains a methoxy substituent at the 5-position of the indole framework.
Its side-chain nitrogen bears two methyl substituents.
These structural features distinguish 5-MeO-DMT from other substituted tryptamines with different ring or nitrogen substitution patterns.
The fumarate designation also distinguishes this preparation from other salt forms of the same parent compound.
However, salt designation alone does not establish experimentally verified solubility, stability, or other physicochemical characteristics.
The source does not provide measured melting-point data, degradation profiles, or complete physical characterization.
It also does not provide a verified quantitative comparison between the fumarate preparation and the corresponding hydrochloride preparation.
The source recommends cool, dry storage protected from light and moisture.
No validated product-specific stability study or established shelf-life specification accompanied that recommendation.
Purity & Analytical Verification
The supplied source states that batch-specific purity information may be available through a Certificate of Analysis.
However, it does not provide a numerical purity specification or an actual analytical report.
No batch-specific chromatogram, mass spectrum, NMR spectrum, or independent laboratory certificate accompanied the information.
Accordingly, no particular purity threshold can be presented as independently verified.
The source identifies analytical method development and reference-oriented research as the intended laboratory context.
Chemical characterization may involve examination of molecular identity, salt composition, structural features, impurity profiles, and analytical specificity.
However, naming a research context does not establish that the actual product has undergone a particular analytical test.
The source also describes the material as a reference material.
That description does not establish certified reference-material status or validated quantitative calibration performance.
No assigned measurement values, uncertainty statements, metrological traceability records, or independently verified analytical specifications were supplied.
Any definitive product-specific analytical claims should be supported by actual batch documentation.
Quality Control & Batch Integrity
The supplied source refers to Certificates of Analysis, lot tracking, and laboratory verification where applicable.
These statements describe proposed or claimed quality-assurance practices.
No actual certificate, independent testing report, manufacturing audit, laboratory accreditation record, or batch-specific quality-control document accompanied the information.
They therefore remain unverified supplier statements.
For reproducible scientific documentation, relevant records may include verified chemical identifiers, confirmed salt composition, batch number, analytical findings, receipt date, and available storage history.
The chemical form of the active ingredient should also be documented.
The supplied information does not establish independently verified purity, fumarate stoichiometry, or batch consistency.
The existence of a Research Use Only designation does not itself demonstrate manufacturing quality or analytical traceability.
Claims of consistent purity, identity, and manufacturing quality should be supported by actual records rather than inferred from general quality-assurance language.
Safety, Handling & Laboratory Precautions
5-MeO-DMT is a synthetic substituted tryptamine associated with potentially significant toxicological hazards.
The supplied source does not provide a complete product-specific toxicological assessment.
Laboratory personnel should consult applicable chemical-safety documentation and institutional procedures before receiving or examining the material.
Relevant precautions include restricted access, appropriate protective equipment, contamination prevention, accidental-exposure procedures, and chemical-waste management.
The fumarate salt presentation does not establish safety for human or veterinary exposure.
The material should remain secured against unauthorized access and separated from food, beverages, and non-research environments.
Because the actual salt composition, purity, and physical characteristics have not been independently confirmed, laboratory documentation should distinguish verified characteristics from supplier-provided statements.
Any accidental exposure or contamination incident should be managed according to institutional emergency procedures.
Packaging, Labeling & Storage
The supplied source describes protective packaging, controlled handling, and professional shipment arrangements.
No actual packaging specification, container-validation report, or shipment-condition record was provided.
The source recommends sealed storage in a cool, dry environment protected from light and moisture.
No validated product-specific stability data was provided to establish a particular storage temperature or shelf life.
Laboratory inventory records should preserve the product designation, confirmed chemical form where available, any batch identifier, receipt details, and relevant storage observations.
Packaging and environmental requirements should be assessed using available safety documentation, relevant stability evidence, and institutional laboratory procedures.
The source’s general handling recommendations should not be interpreted as evidence of validated long-term stability.
Intended Research Use & Market Positioning
The supplied scientific context places 5-MeO-DMT fumarate within analytical research involving substituted tryptamines, 5-methoxytryptamine derivatives, and chemical identification.
The fumarate designation provides a chemically relevant distinction from other salt preparations of the named parent compound.
The source describes the material as intended for controlled laboratory settings and reference-oriented scientific workflows.
These statements identify a research context but do not establish certified reference-material status or validated performance for the actual powder.
The supplied Raw Lab Chems catalog includes 5-MeO-DMT Powder (Fumarate), corresponding to the listing discussed here.
A separate 5-MeO-DMT Hydrochloride Powder listing refers to a different salt designation of the same named parent compound.
The supplied information does not establish equivalent purity, salt stoichiometry, molecular weight, or analytical characteristics between these preparations.
The catalog also includes 5-Bromo-DMT Powder, which refers to a differently substituted tryptamine and should not be treated as chemically identical or analytically interchangeable with 5-MeO-DMT.
These references provide catalog context rather than evidence of product equivalence or certified reference-material status.
Ordering, Availability & Fulfillment
The supplied source describes protective packaging and international shipping arrangements.
No current inventory record, shipment authorization, carrier documentation, or verified delivery information was supplied.
Consequently, no availability, delivery, customs-clearance, or transportation-compliance guarantee is asserted.
5-MeO-DMT and related substituted tryptamines may be subject to controlled-substance, analogue, pharmaceutical, or other chemical regulations depending on the jurisdiction.
Institutional acquisition, possession, transportation, importation, and exportation must be assessed under applicable laws.
Research-only labeling does not establish a legal exemption.
Legal & Regulatory Disclaimer
For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.
5-MeO-DMT is a synthetic substituted tryptamine whose possession, acquisition, transfer, transportation, importation, exportation, and laboratory investigation may be restricted or prohibited depending on the jurisdiction.
The supplied information does not establish universal legal status or regulatory authorization.
Institutions remain responsible for determining the applicable legal requirements and obtaining any necessary permissions.
No medical approval, consumer-use authorization, or regulatory exemption is implied by this description.
| Quantity (mg) |
250 ,500 ,1000 ,2500 ,5000 |
|---|
You must be logged in to post a review.

Reviews
There are no reviews yet.